July 20 (Reuters) - Australia's competition watchdog on Thursday raised concerns over Australian Clinical Labs' (ACL) A$1.52 billion ($1.03 billion) buyout offer for medical centre operator Healius (HLS) , who had rejected the proposal in May.
The Australian Competition and Consumer Commission said the acquisition would lessen competition in the Australian pathology services markets.
($1 = 1.4775 Australian dollars)
July 20 (Reuters) - Australia's competition watchdog on...
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add HLS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.25 |
Change
0.020(1.63%) |
Mkt cap ! $900.3M | |||
| Open | High | Low | Value | Volume |
| $1.23 | $1.26 | $1.23 | $1.916M | 1.536M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10917 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.26 | 15582 | 2 |
View Market Depth
| Last trade - 16.10pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.25 |
Change
0.020 ( 1.60 %) |
||||
| Open | High | Low | Volume | ||
| $1.24 | $1.26 | $1.23 | 437337 | ||
| Last updated 15.59pm 10/05/2024 ? | |||||
| HLS (ASX) Chart |